https://tautonagroup.com/https://tautonagroup.com/https://tautonagroup.com/https://tautonagroup.com/
  • Home
  • About
  • Team
  • Creations
  • Media
  • Contact

Theris Medical Patch

Theris Medical Patch

This is the first biopharmaceutical innovation created by the team at TauTona Group and based upon technology developed over years of research in Dr. Gurtner’s lab at Stanford University. In his research, Dr. Gurtner identified that deferoxamine, a drug sickle cell patients already use intravenously for removing excess iron in the blood could have a favorable effect on healing sickle cell leg ulcers if applied topically. TauTona licensed the technology to transition the novel wound care treatment from the lab to the clinic. FDA Orphan Drug Designation was granted and we are starting clinical trials in Q3 2020. To learn more, visit therismedical.com.

Featured Tautona Medical Devices

Theris Medical Patch

View more

Theris Medical Patch

Theris Medical Patch

Theris Medical Patch
2020-05-16

Thread Tech

View more

Thread Tech

Thread Tech

Thread Tech
2017-03-08

Cell Sponge

View more

Cell Sponge

Cell Sponge

Cell Sponge
2017-03-06

Nipple Reconstruction

View more

Nipple Reconstruction

Nipple Reconstruction

Nipple Reconstruction
2017-03-06

Tissue Injector

View more

Tissue Injector

Tissue Injector

Tissue Injector
2015-08-15

Skin Splint

View more

Skin Splint

Skin Splint

Skin Splint
2015-08-15

Contact

604 Fifth Avenue, Suite D, Redwood City, CA 94063
Phone +1 (650) 503-8250

Copyright 2022 Tautona Group, All Rights Reserved | Legal Notices and Disclaimers
  • Home
  • About
  • Team
  • Creations
  • Media
  • Contact
https://tautonagroup.com/